May 2005
Volume 46, Issue 13
ARVO Annual Meeting Abstract  |   May 2005
Phacoemulsification With IOL Implantation and Vitrectomy in Severe Proliferative Diabetic Retinopathy
Author Affiliations & Notes
  • A. Amaya–Espinosa
    Retina, APEC, Mexico, Mexico
  • R. Bueno Garcia
    Retina, APEC, Mexico, Mexico
  • A. Perez–Reguera
    Retina, APEC, Mexico, Mexico
  • A. Meza de Regil
    Retina, APEC, Mexico, Mexico
  • H. Quiroz Mercado
    Retina, APEC, Mexico, Mexico
  • Footnotes
    Commercial Relationships  A. Amaya–Espinosa, None; R. Bueno Garcia, None; A. Perez–Reguera, None; A. Meza de Regil, None; H. Quiroz Mercado, None.
  • Footnotes
    Support  Fundacion Rio Arronte
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 345. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      A. Amaya–Espinosa, R. Bueno Garcia, A. Perez–Reguera, A. Meza de Regil, H. Quiroz Mercado; Phacoemulsification With IOL Implantation and Vitrectomy in Severe Proliferative Diabetic Retinopathy . Invest. Ophthalmol. Vis. Sci. 2005;46(13):345.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: To evaluate the outcome of patients with severe proliferative diabetic retinopathy (SPDR) in whom vitrectomy and phacoemulsification with IOL implantation was performed. Cataract surgery was done at the same time of vitrectomy in one group and at a second time after vitrectomy in another group. Methods: Patients with SPDR. In subjects with cataract at the time of vitrectomy combined surgery was performed (group 1) and in patients without cataract at the time of vitrectomy who develop cataract in the postoperative period secuential surgery was done (group 2). Main outcome factors were initial and final visual acuities, complications during and after the procedures and progresion of retinopathy. Results: 14 patients in group 1 and 16 in group 2, use of silicon oil in 71.5 % and 75% respectively. Intraoperative complications in 71.4% (group 1) and 62.5% (group 2); postoperative complications in 28.6 % (group 1) and 12.5% (group 2). Visual acuity 20/400 or better in 14.28% in group 1 and 25% in group 2. Conclusions: We found similar results in both groups, there is a tendency to less postoperative complications and better outcome for secuential surgery in patients with SPDR. Silicon oil is very useful in the surgical management of these patients

Keywords: vitreoretinal surgery • diabetic retinopathy • cataract 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.